Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fibrinogen Aalpha-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolism.

Thrombosis research - 1 Jan 2007

Le Gal Grégoire, Delahousse Bénédicte, Lacut Karine, Malaviolle Vincent, Regina Sandra, Blouch Marie-Thérèse, Couturaud Francis, Mottier Dominique, Oger Emmanuel, Gruel Yves

Abstract excerpt

INTRODUCTION: Fibrinogen Aalpha-Thr312Ala and Factor XIII Val34Leu polymorphisms have been shown to modify fibrin clot structure and function. However, clinical studies have yielded conflicting results on their possible association with venous thromboembolism (VTE). METHODS: We studied the associ...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Amino Acid Substitution
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor V

Share to Fibrinogen

Share to Point Mutation

Share to Pulmonary Embolism

Share to Venous Thromboembolism

Source

Identifiers

PMID: 17568659
DOI: 10.1016/j.thromres.2007.05.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17568659-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fibrinogen Aalpha-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolism.PMID 17568659Read ↗

Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis.Semantic proximity Read ↗

The association of alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism in the LITE study.Semantic proximity Read ↗

The factor XIII Val34Leu polymorphism: is it protective against idiopathic venous thromboembolism?Semantic proximity Read ↗

The FXIII Val34Leu polymorphism in venous and arterial thromboembolism.Semantic proximity Read ↗

α-Fibrinogen Thr312Ala polymorphism and venous thromboembolismSemantic proximity Read ↗

Association of a common polymorphism in the factor XIII gene with venous thrombosis.Semantic proximity Read ↗

Fibrinogen Aalpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension.Semantic proximity Read ↗

Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis.Semantic proximity Read ↗

Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.Semantic proximity Read ↗

Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis.Semantic proximity Read ↗

Factor XIII levels and factor XIII B subunit polymorphisms in patients with venous thromboembolism.Semantic proximity Read ↗

Frequency of the TAFI -438 G/A and factor XIIIA Val34Leu polymorphisms in patients with objectively proven pulmonary embolism.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.